EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway

Shan-Ping Ye iD, Hong-Xin Yu, Wei-Jie Lu, Jun-Fu Wang, Tai-Yuan Li, Jun Shi, Xiao-Ye Cheng

International Journal of Genomics · 08.08.2023 · 2023 · 1-16

DOI: 10.1155/2023/9731675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Genomics, erschienen am 08.08.2023. Verfasst von Shan-Ping Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang, Jiangxi Province 330006, C…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal stratifin (SFN) expression is closely related to the progression of several human cancers, but the potential roles of SFN in hepatocellular carcinoma (HCC) remain largely unknown. In this study, we found that SFN was upregulated in HCC cell lines and tissues and was positively associated with tumor size, poor differentiation, Tumor Node Metastasis (TNM) stage, and vascular invasion. In addition, high expression levels of SFN were associated with poor overall survival and disease-free survival. Biologically, downregulation of SFN suppressed tumor cell proliferation, epithelial–mesenchymal transition (EMT), invasion, and migration in vitro and tumor growth in vivo. However, overexpression of SFN promoted cell proliferation, EMT, invasion, and migration in vitro and tumor growth in vivo. Mechanistically, overexpression of SFN activated the Wnt/β-catenin pathway by promoting Glycogen synthase kinase-3 beta (GSK-3β) phosphorylation, decreasing β-catenin phosphorylation, promoting β-catenin transport into the nucleus, and enhancing the expression of c-Myc, whereas depletion of SFN inhibited the Wnt/β-catenin pathway. In addition, TOPFlash/FOPFlash reporter assays showed that overexpression or downregulation of SFN obviously increased or decreased, respectively, the activity of the Wnt/β-catenin pathway. Our results indicated that SFN plays an important role in HCC, possibly providing a prognostic factor and therapeutic target for HCC.

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang, Jiangxi Province 330006, China.
  • Department of Hematology, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang, Jiangxi Province 330006, China.

ORCID-Profile: Shan-Ping Ye

Zitieren

APA

Ye, S. P., Yu, H. X., Lu, W. J., Wang, J. F., Li, T. Y., Shi, J., & Cheng, X. Y. (2023). Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway. International Journal of Genomics, 2023, 1-16. https://doi.org/10.1155/2023/9731675

Vancouver

Ye SP, Yu HX, Lu WJ, Wang JF, Li TY, Shi J, et al. Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway. International Journal of Genomics. 2023;2023:1-16. doi:10.1155/2023/9731675

BibTeX
@article{Ye2023,
  author = {Ye, Shan-Ping and Yu, Hong-Xin and Lu, Wei-Jie and Wang, Jun-Fu and Li, Tai-Yuan and Shi, Jun and Cheng, Xiao-Ye},
  title = {Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway},
  journal = {International Journal of Genomics},
  year = {2023},
  volume = {2023},
  pages = {1--16},
  doi = {10.1155/2023/9731675}
}
Kostenlos starten →